Mean serum D-dimer level to predict in-hospital mortality in COVID-19

Mert İlker Hayıroğlu1, Vedat Çiçek2, Şahhan Kılıç2

  • 1Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.

Revista Da Associacao Medica Brasileira (1992)
|September 1, 2021
PubMed

Insights

Elevated mean D-dimer levels during hospitalization for coronavirus disease-2019 (COVID-19) significantly predict in-hospital mortality. Closer patient monitoring and aggressive treatment may be warranted for those with higher mean D-dimer readings.

Area of Science:

  • Medical research
  • Clinical diagnostics
  • Infectious disease epidemiology

Background:

  • The prognostic impact of early hospitalization mean serum D-dimer levels in COVID-19 patients remains unclear.
  • D-dimer, a marker of coagulation activation, is frequently elevated in severe COVID-19.

Purpose of the Study:

  • To investigate the association between mean D-dimer levels within the first five days of hospitalization and in-hospital mortality in COVID-19 patients.
  • To determine if mean D-dimer can serve as a prognostic biomarker for COVID-19 outcomes.

Main Methods:

  • An observational retrospective study involving 240 adult COVID-19 patients.
  • Mean D-dimer calculated from days 1, 3, and 5 of hospitalization.
  • Patients stratified into tertiles based on mean D-dimer; mortality rates compared. Receiver operating curve (ROC) analysis performed.

Main Results:

  • After adjusting for baseline variables, patients in the highest tertile of mean D-dimer had a 4.2-fold increased hazard ratio for in-hospital mortality (OR 4.2; p<0.001).
  • ROC analysis identified an optimal cutoff value of 779 μg/L for mean D-dimer to predict in-hospital mortality, with 77% sensitivity and 83% specificity (AUC 0.87; p<0.001).

Conclusions:

  • Higher mean D-dimer levels in hospitalized COVID-19 patients are a significant predictor of in-hospital mortality.
  • Patients with elevated mean D-dimer warrant closer monitoring and consideration for aggressive treatment strategies, including biologic agents or convalescent plasma.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
74
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
75
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
437
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
87